# XADAGO
> **NDA207145** · New Drug Application · Sponsor: MDD US · Approved 2017-03-21
## Drug
- **FDA Application Number:** NDA207145
- **Application type:** New Drug Application
- **Brand name:** XADAGO
- **Generic name:** SAFINAMIDE MESYLATE
- **Active ingredients:** SAFINAMIDE MESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MDD US
- **Manufacturer:** MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
- **First approval:** 2017-03-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207145)
---
*AI Analytics · CC0 1.0*